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SUMMARY
Hypertonic saline inhalation has become a cornerstone in
the treatment of cystic ﬁbrosis (CF), but its effect on CF
mucus is still not understood. In CF, mucus stagnates in the
airways, causing mucus plugging, and forming a substrate
for bacterial invasion. Using horizontal Ussing-type cham-
bers to allow easy access to the tissue, we have recently
shown that the small intestinal mucus of CF mice is
attached to the epithelium and not freely movable as
opposed to normal mucus, thus pointing to a similarity
between the CF mucus in the ileum and airways. In the
same type of system, we investigated how hypertonic saline
affects mucus thickness, attachment and penetrability to
ﬂuorescent beads the size of bacteria in ileal explants from
the cystic ﬁbrosis transmembrane conductance regulator
mutant (DF508) mouse, in order to characterize how this
common therapy affects mucus properties. Hypertonic saline
(1.75–5%) detached the mucus from the epithelium, but the
mucus remained impenetrable to beads the size of bacteria.
This approach might be used to test other mucolytic inter-
ventions in CF.
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INTRODUCTION
Cystic ﬁbrosis (CF) is a recessive genetic disease caused by
mutations in the cystic ﬁbrosis transmembrane conductance regu-
lator (CFTR), where the most common mutation is a deletion of
phenylalanine 508 (DF508).1 The CFTR channel is a chloride
channel localized to the apical membrane of epithelial cells.2
More recently, it was found to also transport bicarbonate ions.3
CF is characterized by tenacious mucus, most noticeably affect-
ing the lungs, pancreas and the intestine.4,5 It is only during
recent years that the link between CFTR dysfunction and the
altered mucus properties has started to be clariﬁed. We have
recently shown that sufﬁcient bicarbonate at the site of mucus
release in the small intestine is necessary for unpacking mucins.
Thus, tissue lacking functional CFTR yields a dense mucus that
is attached to the epithelium, something that can be compensated
for by adding 100 mmol/L bicarbonate.6 Correction of the dys-
functional CFTR channel causing CF is the ultimate goal in the
effort to develop an efﬁcient cure, a feat that has been accom-
plished recently for one particular and rare mutation, G551D.7
However, for the vast majority of CF patients, this manner of
therapy is not available, and it is more difﬁcult to envision such
speciﬁc therapies for all CF-causing mutations. Hence, other
treatments not directly targeting CFTR malfunction must be stud-
ied and evaluated.
Current CF therapies are a combination of lung drainage meth-
ods, pancreatic enzyme replacement and an active antibiotic treat-
ment strategy.8 Recently, inhalation of hypertonic saline (HS)
solutions has been introduced and widely used with good
effects.9,10 HS has been shown to improve lung function in CF
patients, as evaluated in a number of clinical studies.9,10 How-
ever, the mechanism for the HS effect on the mucus remains lar-
gely unknown, except for a few in vitro studies that suggest
alternative mechanisms for the beneﬁcial effect of this treat-
ment.10–12 We have developed an experimental method where
mucus can be studied and its properties evaluated after secretion
from ileal explants.6 CF patients commonly have intestinal prob-
lems, including meconium ileus and distal intestinal obstruction
syndrome. CF mice have a similar intestinal phenotype, which
can be controlled by adding salts and polyethylene glycol (a mild
laxative) to the drinking water, in conjunction with a liquid diet
if required.13 We have previously shown that for proper unfold-
ing of the MUC2 mucin, the calcium and hydrogen ions bound
to the mucin when packed in the goblet cell granule must be che-
lated on release.14 This is accomplished by bicarbonate ions che-
lating calcium and increasing the pH. When this mechanism is
compromised, as in CF, the mucin is insufﬁciently unfolded and
is attached to the epithelium.6 Using normal homozygous wild-
type (WT) and CF (DF508, Cftrtm1eur) mice, and a modiﬁed
Ussing-type set up, we have now studied how HS affects CF
mouse ileum mucus properties in terms of thickness, attachment
and penetrability.
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RESULTS
Mucus in WT C57BL/6 mouse ileum forms a loose layer that is
easily aspirated, whereas the mucus in the CF mouse is denser
and difﬁcult to aspirate.6,15 The differences between the WT and
CF mucus are clearly illustrated by a video showing the mucus
formed on ileal tissue mounted in a horizontal Ussing-type
chamber, where the otherwise transparent mucus is visualized by
surface charcoal.16 Initial and ﬁnal frames from video recordings
of WT are shown in Fig. 1a and Movie S1, and from a CF
mouse in Fig. 1b and Movie S2. The WT mucus is easily
removed, whereas CF mucus is attached to the tissue and can be
moved around, but not aspirated.
To further show the difference between mucus in WT and CF
mice, Carnoy-ﬁxed parafﬁn-embedded sections were stained with
the anti-MUC2-C3 antibody (green), directed against the main
mucus component, the Muc2 mucin. In sections from WT mice,
mucus is sparse in the crypts (Fig. 2); but in the sections from
CF mice, mucus ﬁlls the crypts, making them appear dilated and
clogged with mucus as reported previously for this mouse
strain.13 As we have previously shown, there are also more gob-
let cells per crypt in the CF mouse ileum.6
Because HS is an accepted treatment for CF lung disease, we
wanted to know if and how mucus was affected in our experi-
mental system. After the ileal tissue was mounted in the Ussing
chamber and temperature equilibrated, the apical solution was
replaced with increasing amounts of NaCl in normal Krebs’ buf-
fer, to make the solution hypertonic. After 1 h, during which tis-
sue viability was constantly assessed by transepithelial PD
recording, the mucus thickness was measured, mucus that could
be aspirated was removed and the thickness of the remaining
mucus measured. As shown previously, CF mucus secreted into
physiological NaCl (0.9%) could not be aspirated in contrast to
WT mucus, which could be aspirated (WT Fig. 3a and CF
Fig. 3b).6 Mannitol inhalations are also used to improve lung
function in CF patients.17 In our experimental set up, the attached
CF mouse ileal mucus became easily aspirated after 1 h incuba-
tion with 70 mmol/L mannitol (Fig. 3a, compare 0.9% NaCl and
10 mmol/L mannitol in Fig. 3b). When the mannitol concentra-
tion was kept at 10 mmol/L, the CF mucus detachment was
dependent on NaCl concentrations, and it was still not possible to
aspirate CF mucus after incubation with 1.0% and 1.5% NaCl.
However, when incubating with 1.75% and higher concentrations
(up to 5%) of HS, the CF mucus could be aspirated (Fig. 3b). To
further visualize this effect, a movie of CF explants incubated
with 2% for 40 min was recorded (Fig. 1c; Movie S3). As
shown, this treatment made it possible to aspirate the CF mucus,
leaving the intervillus space almost as empty as in WT tissue.
As can be observed in Fig. 3b, the mucus thickness increased
after exposure to HS. This increase in thickness is further shown
in Fig. 3c. The mucus thickness did not increase signiﬁcantly
when incubated with 1%, 1.5% or 1.75% NaCl (170, 260 or
300 mmol/L, respectively). When the apical solution contained
2%, 3%, 4% or 5% NaCl (340, 510, 680 or 860 mmol/L, respec-
tively) the mucus thickness before aspiration increased by
71  12, 137  62, 145  50 and 90  47 lm, respectively
(Fig. 3c). Importantly, at 1.75% the mucus could be easily aspi-
rated, and therefore the increase in mucus thickness did not cor-
relate with this parameter under these conditions. Apical
incubation with HS pulls water from the epithelial cells and
causes cell shrinkage. It is likely that the increased mucus thick-
ness is caused by liquid drawn out of the epithelial cells and into
the mucus. The hypertonic solution also increased cell shedding
from the villi tips, identiﬁed as small blebs in the mucus (Fig. 1c,
right). This effect explains why the villi looked slightly
deformed, but it should be noted that treatment did not cause
complete disruption of the tissue. The transepithelial potential dif-
ference (PD) remained stable and normal up to 5% NaCl, aside
(a)
(b)
(c)
Fig. 1 Ileal mucus in cystic ﬁbrosis (CF) mice was attached to the epi-
thelium, but can be detached by treatment with hypertonic saline. (a)
Movie (Movie S1) showing aspiration of easily removable normal homo-
zygous wild-type (WT) mucus from an ileal explant mounted in the Us-
sing-type chamber. The ﬁrst (left) and last (right) frames of the movie are
shown in the printed manuscript. (b) Movie (Movie S2) showing attempt
to aspirate the attached CF mucus from an ileal explant mounted in the
Ussing-type chamber. The ﬁrst (left) and last (right) frames of the movie
are shown in the printed manuscript. Movies in (a) and (b) are representa-
tive of more than 10 animals of each genotype. (c) Movie (Movie S3)
showing aspiration of CF mucus after treatment with 2% NaCl for
40 min from an ileal explant mounted in the Ussing-type chamber. The
ﬁrst (left) and last (right) frames of the movie are shown in the printed
manuscript. Arrows in (right) indicate blebs formed from the villi tips
after hypertonic saline incubation, although they are difﬁcult to observe
in 2-D images. Bar, 1 mm.
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from a transient dip concurrent with the addition of HS. How-
ever, at higher NaCl concentrations the normal PD was lost,
reﬂecting loss of tissue viability.
The mucus in WT small intestine is normally penetrable to
bacteria, whereas the CF mucus is not.6,15 Penetrability can be
assessed by applying ﬂuorescent beads with sizes corresponding
to small bacteria (in this case, 2 lm). The beads were placed on
top of the mucus formed on explants and were allowed to sedi-
ment for 60 min. Confocal z-stacks were acquired to evaluate
mucus penetrability. In WT mice, the ﬂuorescent beads (green)
penetrated the mucus and sedimented down between the villi (tis-
sue stained blue, Fig. 4a). In the CF mice, the beads were
trapped at the surface of the mucus (Fig. 4b,c). In some CF tis-
sues, the beads penetrated to the villus tips without penetrating
the mucus between the villi; but in others, mucus separated the
beads from the villi tips (Fig. 4c–e). When the CF mucus was
incubated with 2% NaCl for 30–60 min, there was no increase in
beads penetration. Instead, the increased mucus thickness
(Fig. 3c) separated the beads and villi tips further (Fig. 4c,d). In
some locations on two explants, the mucus was penetrable
(Fig. 4f), a proﬁle that is occasionally observed in this non-uni-
form system. Despite this variability, the mean separation of
beads from villi tips was larger in CF ileum treated with HS (2%
NaCl, 165  37 lm) compared with untreated CF ileum (0.9%
NaCl, 43  14 lm), as shown in Fig. 5.
DISCUSSION
Although the basis for CF is a dysfunctional CFTR channel, the
relationship of this defect to actual CF disease manifestations has
been controversial, and there is still no uniform understanding of
the reason for chronic lung infections. There are two major and
partly opposing models for the consequences of CFTR dysfunc-
tion, one suggesting that the antibacterial peptides and proteins
are less efﬁcient, and the other that the pericilliary liquid is
(a) (b)
Fig. 2 Mucus in cystic ﬁbrosis (CF) mouse ileum accumulated in the
crypts. (a) Immunostaining of Muc2 (green) and nuclei (blue) in normal
homozygous wild-type (WT) mouse ileal crypts. (b) Immunostaining of
Muc2 (green) and nuclei (blue) in CF mouse ileal crypts. Bar, 20 lm,
representative images of n = 5 in each group. Cr, crypt; EC, epithelial
cell; GC, goblet cell; M, mucus.
(a)
(b)
(c)
Fig. 3 Mucus was easily aspirated after incubation with hypertonic sal-
ine. (a) Mucus thickness was measured immediately before aspiration
(white bars) and again after aspiration from normal homozygous wild-
type (WT) small intestinal explants (black bars; **P = 0.008, n = 5), and
with 70 mmol/L mannitol before aspiration (white bars) and after aspira-
tion from cystic ﬁbrosis (CF) small intestinal explants (black bars;
**P = 0.008, n = 5). (b) Mucus thickness was measured immediately
before aspiration and again after aspiration from CF explants. Mucus
thickness after aspiration was signiﬁcantly different from before aspiration
in CF explants with 1.5% NaCl (*P = 0.03), 1.75–4% NaCl
(**P = 0.008), and 5% NaCl (*P = 0.02; n = 5). Note that 1.75% NaCl
did not increase mucus thickness, but did release mucus from its epithelial
attachment. (c) Mucus thickness increased over 1 h on CF ileal explants
(n = 5) mounted in the chamber and incubated with apical solutions con-
taining increasing concentrations of NaCl (*P < 0.05 compared with
0.9% NaCl and &P < 0.05 compared with 1% NaCl).
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decreased, causing mucus to be trapped in the cilia and entangled
in the glycocalyx.18,19 The latter model was initially suggested to
be caused by hyperabsorption of sodium, but is more likely a
result of decreased chloride and water efﬂux.19,20 More recently,
the gel-on-brush model was proposed, indicating an electron-
dense meshwork of transmembrane mucins between the cilia,
resulting in a double-layered system. Also, this model suggests
that the stagnant mucus characteristic of CF and COPD is a result
of dehydration of mucus.21,22 Irrespective of aetiology, the lungs
of CF patients show poor bacterial clearance through the muco-
ciliary system. Recently, it was suggested that the mucus strands
formed from submucosal glands are attached in Cftr/ but not
Cftr+/+ piglets. This is extremely interesting, because it suggests
that there is a mucus phenotype before there is any sign of bacte-
rial infection or inﬂammation in the lungs.23 Because the lungs
are the main site of the severe and life-shortening CF problems,
less emphasis has been put on other organs. Among other hall-
marks of CF are the salty sweat and plugged tubes of secretory
organs, such as the pancreas, seminal ducts and biliary tree. Less
attention has also been directed to the small intestine despite the
high frequency of meconium ileus and distal obstruction syn-
drome. We have focused on this organ because the movement of
mucus is slower and the main structural component is the MUC2
mucin, and because mouse CF models, both the full knock-out
and DF508-Cftr, have an intestinal pathology similar to
humans.13 Our previous studies have shown that, in contrast to
WT, the CF small intestinal mucus is attached to the epithelium,
and that this a result of diminished unfolding of the intestinal
MUC2 mucin. This was shown to be caused by insufﬁcient
concentrations of HCO3 during mucin secretion.
6 Hence, the
important ion in this context is not chloride, but bicarbonate. We
have also shown that selective CFTR inhibitors only cause 70%
inhibition of the forskolin response in this set up, and this level
of inhibition is not sufﬁcient to cause induction of the CF pheno-
type (i.e. attached mucus) in the ileal explants. However, when
the serosal solution was devoid of bicarbonate, the WT pheno-
type of detached mucus could be reverted to a CF-like phenotype
with attached mucus. Thus, we conclude that a lack of bicarbon-
ate causes the intestinal CF mucus pathology.6 It is reasonable to
consider that attached mucus might also be a feature of CF
mucus in the airways, and therefore observations regarding the
ileal mucus phenotype could be relevant to the lung.
Although the underlying mechanisms of CF lung problems are
not fully understood, the use of inhaled HS has been a clinically
successful treatment. The use of HS was ﬁrst applied to CF in
Australia, and later spread to the rest of the world after several
promising clinical studies.9,10 The use of HS solution (5–7%) is
now accepted as a cornerstone of CF treatment in most countries.9
The mechanism behind its effect has been suggested to be
improved function of endogenous antibacterial components as a
result of increased salinity of the periciliary layer (PCL) along
with increased PCL depth caused by increased osmolality. A
decreased PCL height in CF has been observed in human bron-
chial epithelial cultures obtained from CF patients in comparison
with controls. It was also noticed that the mucus was intermingled
and trapped within the cilia.19,21 On normal human bronchial epi-
thelial cultures, the mucus is transported in a circular motion (like
(a) (b) (c)
(d) (e) (f)
Fig. 4 Mucus was impenetrable to beads in the cystic ﬁbrosis (CF)
mouse ileum, also after incubation with 2% NaCl. (a) Ileal mucus formed
on normal homozygous wild-type (WT) mouse explant was penetrable to
2-lm beads (green). Tissue, blue. (b) Ileal mucus formed on CF mouse
explant was not penetrable to 2-lm beads, and the mucus only penetrated
to the tips of the villi (n = 3). (c) In one animal, the separation between
epithelium and beads was even larger, causing a separation between beads
and villi tips. (a–c) The apical solution contained 0.9% NaCl. (d) After
incubation with 2% NaCl in the apical solution for 60 min, the CF mouse
ileal mucus was still impenetrable to beads (n = 6). (e) In some locations
on the CF mouse ileal explants, the separation was similar to untreated
CF mouse ileum. (f) Two of the explants were penetrable in some loca-
tions after incubation with 2% NaCl in the apical solution. Tissues are
blue and beads (Be) are green. Bar, 50 lm. M, mucus, two-sided arrow
denotes mucus thickness; Vi, villus.
Fig. 5 The distance between beads and villi tips was larger in cystic
ﬁbrosis (CF) ileum treated with 2% compared with 0.9% NaCl. Mean
separation of beads from the ileal villi tips in all the locations in CF mice
(n = 3, green bar) and CF mice treated apically with 2% NaCl for 30–
60 min (n = 6, blue bar). The separation was greater after incubation with
hypertonic saline, *P = 0.001.
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a ‘hurricane’), whereas on cell cultures from CF patients, the
mucus is immobile. When the PCL is too low, the mucus does
not ﬂoat on top of the cilia, the cilia cannot beat, and the mucus is
trapped and immobile.19 This model of trapped mucus is attractive
as an explanation for the CF lung phenotype, because it suggests
why clearance of bacteria from the lungs is poor.
Using methods developed for studies of the small intestinal
mucus system, we have now shown that incubation of CF mucus
with HS, from 1.75% to 5% NaCl, for 1 h on already formed CF
intestinal mucus, released it from its attachment to the epithelium.
The mucus also increased in thickness at the higher NaCl con-
centrations, but this was not the case at 1.75% NaCl, the lowest
concentration when the mucus became easily removable. Thus,
the thickness increase is not strictly coupled to release from
attachment. It was also noticed that the increased mucus thick-
ness did not cause the mucus to become penetrable to bacterial
sized beads, showing that the mucus gel network is not affected
by HS at these lower concentrations. Indeed, the beads were still
trapped in the mucus, further indicating that some aspects of
mucus properties were not affected by HS. Together, these results
suggest that the thickness increase is not coupled to the release
of mucus from its attachment, and that the mucus release and
detachment are separate processes. We cannot fully explain the
mechanism behind the detachment of mucus by HS, but it is not
a result of increased bicarbonate concentration, as it is highly
unlikely that HS stimulates carbonic anhydrase to cause forma-
tion of bicarbonate to the extent that the apical concentration
reaches 100 mmol/L. Furthermore, carbonic anhydrase is the only
conceivable source of bicarbonate, as the serosal concentration of
bicarbonate is 23 mmol/L in this experimental set up. It is also
highly unlikely that the tissue itself could concentrate bicarbonate
to 100 mmol/L by selective transport. Furthermore, bicarbonate
induces penetrable mucus in the CF mouse ileum, whereas HS
does not affect CF mucus impenetrability.6 We conclude that
treatment of CF small intestinal mucus with HS causes detach-
ment of mucus from the epithelium by a process unrelated to
bicarbonate. Bacteria are trapped in the mucus and cleared when
mucus is removed.
Although our observations cannot be directly transferred to the
respiratory system, we can still suggest similarities. If mucus could
be more easily removed from the lungs, this should be beneﬁcial
for the CF patient, as it would avoid mucus stagnation and bacterial
overgrowth. From the present results, it is apparent that the increase
in NaCl concentration does not have to be dramatic to obtain a sig-
niﬁcant effect on the mucus, as increasing the NaCl concentration
from 0.9% in the normal Krebs’ buffer to 1.75% was sufﬁcient to
detach the mucus. Interestingly, assuming an airway liquid volume
of 2 mL and a 15% distribution (GASTROPLUS 8 software, Simula-
tions Plus, Lancaster, CA) shows that inhaling a 7% NaCl solution
could result in local NaCl concentrations in the range that caused
observable mucus detachment in our system.
The remaining question is the mechanism for HS in the ileum.
The HS-induced CF mucus detachment was mimicked by apical
incubation of the ileal explants with a 70-mmol/L mannitol solu-
tion, showing that osmolarity rather than ionic strength is essen-
tial for mucus detachment. This is another parallel to the airways,
where inhaled mannitol has been shown to improve lung func-
tion.24 The thickness increase was moderate, and did not occur at
the same concentrations as the detachment, making it less likely
that the mechanism is linked to drawing water or bicarbonate out
of the epithelium. We have previously shown that the MUC2
mucin is packed in the goblet cell granulae as a result of interac-
tions in the N-terminal part of MUC2 caused by high Ca2+/low
pH.6,14 With intestinal mucus, unfolding requires an increase in
the pH and removal of Ca2+ ions, both of which are mediated by
bicarbonate ions. The increased Na+ concentration will compete
with the Ca2+-binding to the mucin N-terminus and as removal
of Ca2+ is a prerequisite for expansion, Na+ ions can thus pro-
mote mucus unfolding. Unfolding of the MUC2 N-terminus
exposes hidden proteolytic cleavage sites that are necessary for
release of the mucin from its attachment. However, for the respi-
ratory tract, it is not yet known if the mucins are anchored in a
similar way as in the intestine, and if release from the attachment
also requires enzymatic activities.
The techniques used to evaluate mucus thickness and proper-
ties in the gastrointestinal tract have now been proven useful for
the study of CF intestinal mucus.6,16 We have previously shown
that a bicarbonate concentration of 100 mmol/L can release
attached mucus, and we now show that a hypertonic solution of
1.75% NaCl can have the same effect. The present study ﬁndings
suggest that these Ussing-chamber techniques can be valuable for
research and evaluation of therapeutic strategies for treating the
CF mucus phenotypes and its consequences.
METHODS
Animals
Male and female (age 8–16 weeks) homozygous DF508-Cftr mice
on C57BL/6 background (backcrossed for 13 generations) were
obtained from the Erasmus MC animal facility, and bred as het-
erozygotes and with C57BL/6 mice (Taconic) at Gothenburg Uni-
versity as described.13,25,26 Mice were housed in individually
ventilated cages under controlled temperature (21–22°C), humidity
and 12-h light/dark cycle under speciﬁc pathogen-free conditions.
All mice were killed by cervical dislocation under isoﬂurane
anaesthesia. Ethical approval was granted by the Laboratory Ani-
mal Ethics Committee, University of Gothenburg, and experimen-
tal animal care was in accordance with their guidelines.
Explants
Intestinal explants were prepared and mounted as described pre-
viously.16 Brieﬂy, to visualize the otherwise transparent mucus
surface through a stereomicroscope at 940 magniﬁcation (Leica
MZ125, Wetzlar, Germany), activated charcoal particles in
Krebs’ mannitol buffer were added and allowed to sediment on
top of the mucus. Videos were recorded using a Leica IC D 3.3
megapixel camera mounted to the microscope, and mucus was
aspirated with a Pipetman P200 (Gilson, Middleton, WI, USA)
set to 150 lL and a yellow tip. Tissue viability was monitored
by PD (Ref201; Radiometer, Copenhagen, Denmark) connected
to the chamber by agar bridges (4% agar, 0.9% NaCl).
Mucus thickness measurements
Mucus thickness was measured as described, from the mucus
surface to the villus tips every 20 min for 1 h, the last time-point
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being denoted ‘Pre-aspiration’ in the ﬁgures.15 To evaluate mucus
properties, the whole apical volume was aspired using a plastic
Pasteur pipette (PP-101, outer tip diameter 0.9 mm, inner tip
diameter 0.7 mm, maximum volume 800 lL; Cellprojects, Sutton
Valence, UK) by placing the pipette opening at the edge of the
circular opening, taking care not to touch the mounted tissue and
kept in place while releasing the bulb during approximately 3 s,
thus removing all removable liquid. The remaining mucus thick-
ness (denoted ‘Post-aspiration’ in the ﬁgures) was measured after
reﬁlling the apical chamber with 150 lL Krebs’ mannitol to
ensure any mucus material is supported and does not collapse,
and adding new charcoal particles. Finally, the villus height was
measured from the epithelium between the villi to the villi tips.
Total mucus thickness is presented as the sum of villus height
and mucus on top of the villus.
Mucus penetrability
For penetrability measurements, ileal explants from CF and
WT mice were mounted in a horizontal imaging chamber
(RC-50; Warner Instruments, Hamden, CT, USA) with a 1.8-
mm2 opening and 1.5 mL Krebs’ mannitol buffer (in mmol/L:
116 NaCl, 1.3 CaCl2, 3.6 KCl, 1.4 KH2PO4, 23 NaHCO3, 1.2
MgSO4 and 10 D-mannitol, pH 7.4) was added to the apical
chamber. The serosal side was constantly perfused (at a rate of
5 mL/h) with Krebs’ glucose solution (10 mmol/L glucose
instead of mannitol) containing CellTrace BODIPY TR Methyl
Ester (10 lmol/L; Invitrogen, Carlsbad, CA, USA) to visualize
the tissue. As for mucus measurements, the chamber was
heated to 37°C during a period of 10 min, using a temperature
controller (Harvard Apparatus, Holliston, MA, USA), and
thereafter kept at a constant temperature. After temperature
equilibration, the apical buffer was removed, and a 5 lL sus-
pension of 2 lm (green) ﬂuorescent beads (FluoSpheres; Invi-
trogen) in Krebs’ mannitol was added to the apical surface.
The beads were allowed to settle in the mucus for 5 min
before new Krebs’ mannitol buffer was added to the apical
chamber, and then the beads were left to sediment through the
mucus for 30–60 min. Confocal Z-stacks (optical section
2.8 lm, interval 10 lm) were taken to analyse the distribution
of the different beads throughout the mucus, using an upright
LSM 700 Axio Examiner 2.1 confocal imaging system with a
Plan-Apochromat 920/1.0DIC water objective (Carl Zeiss,
Oberkochen, Germany). IMARIS (Bitplane, Zurich, Switzerland)
software was used to process images. Representative Z-stacks
are shown to illustrate bead penetrability.
Immunoﬂuorescent stainings
Whole tissues from CF and WT mice were ﬁxed in Carnoy’s ﬁx-
ative (60% dry methanol, 30% chloroform and 10% glacial acetic
acid), embedded in parafﬁn and cut in 4-lm thick sections. The
sections were dewaxed using Xylene substitute (Sigma, St. Louis,
MO, USA) and hydrated. Antigen retrieval was carried out by
microwave heating in 0.01 mol/L citric buffer pH 6, and the sec-
tions were stained with custom-made anti-MUC2C3 antiserum
(1 : 500) and goat anti-rabbit Alexa 488 secondary antibody
(Invitrogen).27 DNA was stained by TO-PRO-3 Iodide (1 lmol/
L, 642⁄661; Invitrogen). Images were acquired using a ﬂuores-
cence microscope, Eclipse E1000 with a Plan-Fluor 409/0.75
DIC objective (Nikon, Amstelveen, the Netherlands). The pic-
tures were processed uniformly using ADOBE PHOTOSHOP (Adobe,
San Jose, CA, USA).
Data are presented as mean  standard error of the mean
(SEM) for n animals. The Mann–Whitney test was used to test
differences between two groups and the Kruskal–Wallis with
Dunn’s multiple comparisons test was used to test differences
between multiple groups. Statistical signiﬁcance was accepted
when P < 0.05.
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SUPPORTING INFORMATION
Additional Supporting Information may be found in the online version of this article:
Movie S1. Aspiration of easily removable normal homozygous wild-type mucus from an ileal explant mounted in the Ussing-type
chamber.
Movie S2. Attempt to aspirate the attached cystic ﬁbrosis mucus from an ileal explant mounted in the Ussing-type chamber.
Movie S3. Aspiration of cystic ﬁbrosis mucus after treatment with 2% NaCl for 40 min from an ileal explant mounted in the Ussing-
type chamber.
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